Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Survey of Community Support Interventions for Mammography Screenings, Potential Extramural Project (PEP) 2008-R-13, 21136 [E8-8357]
Download as PDF
21136
Federal Register / Vol. 73, No. 76 / Friday, April 18, 2008 / Notices
Dated: April 11, 2008.
Tim Hack,
Deputy Director, Office of Policy, Planning
and Evaluation, National Center for
Environmental Health/Agency for Toxic
Substances and Disease Registry.
[FR Doc. E8–8167 Filed 4–17–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Epidemiology
of Carbapenemase-Producing
Enterobacteriaceae in a Healthcare
Setting, Potential Extramural Projects
(PEP) 2008–R–24
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
pwalker on PROD1PC71 with NOTICES
Time and Date: 1 p.m.–2 p.m., May 15,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Epidemiology of
Carbapenemase-Producing
Enterobacteriaceae in a Healthcare Setting,
PEP 2008–R–24.’’
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Monitoring
Hospitalizations and Outpatient Visits
for Pneumonia and Other Non-Invasive
Pneumonococcal Diseases by Using
National Databases, Potential
Extramural Project (PEP) 2008–R–17
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Survey of
Community Support Interventions for
Mammography Screenings, Potential
Extramural Project (PEP) 2008–R–13
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 1 p.m.–2:30 p.m., May 19,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Monitoring Hospitalizations
and Outpatient Visits for Pneumonia and
other Non-Invasive Pneumonococcal
Diseases by Using National Databases, PEP
2008–R–17.’’
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8356 Filed 4–17–08; 8:45 am]
BILLING CODE 4163–18–P
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 1 p.m.–2:30 p.m., May 20,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Survey of Community Support
Interventions for Mammography Screenings,
PEP 2008–R–13.’’
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8357 Filed 4–17–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): The Effect of
Prenatal Bleeding on Pregnancy
Outcomes in Women With a Previously
Undiagnosed Bleeding Disorder,
Potential Extramural Project (PEP)
2008–R–27
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8355 Filed 4–17–08; 8:45 am]
BILLING CODE 4163–18–P
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
VerDate Aug<31>2005
17:38 Apr 17, 2008
Jkt 214001
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
E:\FR\FM\18APN1.SGM
18APN1
Agencies
[Federal Register Volume 73, Number 76 (Friday, April 18, 2008)]
[Notices]
[Page 21136]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8357]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Survey of Community Support Interventions for
Mammography Screenings, Potential Extramural Project (PEP) 2008-R-13
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 1 p.m.-2:30 p.m., May 20, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of ``Survey of Community Support
Interventions for Mammography Screenings, PEP 2008-R-13.''
Contact Person for More Information: Linda Shelton, Program
Specialist, Coordinating Center for Health and Information Service,
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498-1194.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-8357 Filed 4-17-08; 8:45 am]
BILLING CODE 4163-18-P